SE9702191D0 - Coposition and methods for the treatment of inflammatory dideases - Google Patents

Coposition and methods for the treatment of inflammatory dideases

Info

Publication number
SE9702191D0
SE9702191D0 SE9702191A SE9702191A SE9702191D0 SE 9702191 D0 SE9702191 D0 SE 9702191D0 SE 9702191 A SE9702191 A SE 9702191A SE 9702191 A SE9702191 A SE 9702191A SE 9702191 D0 SE9702191 D0 SE 9702191D0
Authority
SE
Sweden
Prior art keywords
treatment
inflammatory
methods
dideases
coposition
Prior art date
Application number
SE9702191A
Other languages
English (en)
Inventor
Sven Pettersson
Hans Wolf-Watz
Original Assignee
Sven Pettersson
Hans Wolf Watz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sven Pettersson, Hans Wolf Watz filed Critical Sven Pettersson
Priority to SE9702191A priority Critical patent/SE9702191D0/sv
Publication of SE9702191D0 publication Critical patent/SE9702191D0/sv
Priority to EP98928776A priority patent/EP0998492A1/en
Priority to AU80490/98A priority patent/AU8049098A/en
Priority to PCT/SE1998/001106 priority patent/WO1998056817A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9702191A 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases SE9702191D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9702191A SE9702191D0 (sv) 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases
EP98928776A EP0998492A1 (en) 1997-06-09 1998-06-09 Composition and methods for the treatment of inflammatory diseases
AU80490/98A AU8049098A (en) 1997-06-09 1998-06-09 Composition and methods for the treatment of inflammatory diseases
PCT/SE1998/001106 WO1998056817A1 (en) 1997-06-09 1998-06-09 Composition and methods for the treatment of inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702191A SE9702191D0 (sv) 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases

Publications (1)

Publication Number Publication Date
SE9702191D0 true SE9702191D0 (sv) 1997-06-09

Family

ID=20407302

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702191A SE9702191D0 (sv) 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases

Country Status (4)

Country Link
EP (1) EP0998492A1 (sv)
AU (1) AU8049098A (sv)
SE (1) SE9702191D0 (sv)
WO (1) WO1998056817A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112687D0 (en) * 2001-05-24 2001-07-18 Microbiological Res Authority Pharmaceutical use of secreted bacterial effector proteins
CA2513584A1 (en) * 2003-01-20 2004-08-05 Vib Vzw The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors
WO2006109303A2 (en) * 2005-04-11 2006-10-19 Yeda Research And Development Co.Ltd. Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
CA2726193C (en) * 2008-06-03 2018-11-27 University Of Rochester Methods of treating inflammatory intestinal disease and managing symptoms thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903414A (fi) * 1990-07-06 1992-01-07 Kansanterveyslaitos Produktion av proteiner i grampositiva bakterier.

Also Published As

Publication number Publication date
AU8049098A (en) 1998-12-30
EP0998492A1 (en) 2000-05-10
WO1998056817A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
TR200001982T2 (tr) Farmasötik vurulu salınımlı oral dozaj şekli.
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
BR9813284B1 (pt) aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
EE9700192A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
DE69604653T2 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
EE9700194A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
CY1108007T1 (el) Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης
DE69917609D1 (de) Arzneimittel und deren verwendung
IS1846B (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
NO20010078L (no) Fenoksyeddiksyrederivat og farmasøytisk sammensetning omfattende det samme
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
PT1095025E (pt) Benzimidazoles sua producao e sua utilizacao como medicamentos
PT902789E (pt) Derivados de androsteno
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
ATE398630T1 (de) Zyklische conotoxin-peptide
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DK1210119T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
TR199701536T1 (xx) Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�.
PT906092E (pt) Composicoes farmaceuticas baseadas em diclofenac
SE9702191D0 (sv) Coposition and methods for the treatment of inflammatory dideases
DE50105373D1 (de) Dipeptidische hemmstoffe für den gerinnungsfaktor xa